600521 华海药业
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额1,297,8282,217,0211,242,693938,4301,555,458
投资活动产生之现金流量净额(815,411)(1,622,771)(2,432,575)(2,356,859)(1,357,542)
筹资活动产生之现金流量净额(297,007)(644,232)609,0431,118,346596,349
汇率变动对现金及现金等价物的影响43,77028,99854,654(43,491)(85,336)
现金及现金等价物净增加/(减少)229,180(20,984)(526,185)(343,574)708,930
期初现金及现金等价物余额1,306,9661,327,9501,854,1352,197,7091,488,779
期末现金及现金等价物余额1,536,1461,306,9661,327,9501,854,1352,197,709